Skip to main content
SpringerLink
Log in

Pay-for-performance programme has little effect on mortality

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. asthma, chronic obstructive pulmonary disease, chronic kidney disease, diabetes mellitus, hypertension, ischaemic heart disease or stroke (including transient ischaemic attack)

References

  1. Ryan AM, et al. Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study. Lancet : 17 May 2016. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(16)00276-2

    Google Scholar 

  2. Roland M. Does pay-for-performance in primary care save lives? Lancet : 17 May 2016. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(16)00550-X

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pay-for-performance programme has little effect on mortality. PharmacoEcon Outcomes News 754, 21 (2016). https://doi.org/10.1007/s40274-016-3091-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3091-4

Search

Navigation